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Involving Fathers in Ante-natal  
Screening for Sickle Cell Disorders: 
Improving Informed Decision Making
SuMMAry oF reSeArCh ProjeCt FInDIngS
Introduction
Facilitating informed choice among those at risk of recessive disorders is a key NHS policy objective. In 
2001, the Department of Health established the Sickle Cell and Thalassemia Screening Programme (now 
part of Public Health England).  One of the aims of the programme is to provide timely ante-natal sickle cell 
screening to all couples, who might be carriers of sickle cell.  
Sickle cell disorders are inherited blood disorders which can have an impact on a person’s quality of life (for 
more information see www.nhs.uk/conditions/sickle-cell-anaemia/Pages/Introduction.aspx). Both parents 
have to carry a genetic trait (sickle cell trait) before it can be passed on to their offspring.  If they do, there 
is a one-in-four chance in every pregnancy that their child will be born with the disorder.  Carriers can be 
identified by a simple blood test.       
Ante-natal care is the care a woman receives when she is pregnant. During this care choices are offered 
about tests or screening for the woman and her baby. Ante-natal care involves fathers too. If a mother is 
identified as a carrier for sickle cell, ideally the father of the baby should be offered screening. This enables 
the couple to make an informed choice on the future of the pregnancy. Fathers, however, are not always 
tested, even when their partner is a known carrier. Little is known about why this is. Not engaging with 




This qualitative research project was funded by the 
National Institute for Health Research (Research 
for Patient Benefit: Yorkshire and Humber). In 
partnership with voluntary sector organisations, 
it took place across England in Birmingham, 
Manchester, Leeds, Leicester, Liverpool, London, 
Sandwell and Dudley, and Sheffield. 
The study included six focus group discussions 
with 50 young people. These were young people 
who were in relationships, aged 18-35, and from 
ethnic minority groups at possible risk of sickle cell 
disorders. We explored the extent to which men 
and women thought fathers should be involved in 
ante-natal care. We held discussions with men and 
women of African, African-Caribbean and mixed 
ethnic origins. We also conducted 24 in-depth 
semi-structured interviews with fathers to explore 
their experiences of ante-natal screening. In order 
to locate our findings within the ‘realities’ of service 
delivery we undertook 19 telephone interviews 
with professionals and two health commissioners 
involved in ante-natal screening.
We discussed our findings by holding advisory 
groups with stakeholders such as patients, families 
and interested members of the public who were 
primarily from ethnic minority communities. We 
held four advisory groups in London and two in 
Leeds. We also held three steering group meetings 
made up of academic, practice, policy, patient 
and family stakeholders. As the research project 
progressed we presented findings in community 
and practice settings.
Key Findings
There are many reasons why fathers find it difficult 
to be involved in ante-natal screening for sickle 
cell disorders. Some are the consequence of 
disadvantage and inequalities, others are associated 
with how services are organised. Men’s perceptions 
about the relevance of screening are equally 
important, along with their relationship with their 
partners and families. Examples of good practice 
also exist and we can learn from these. Our findings 
and recommendations for policy and practice are 
summarised here.
Ante-natal care as necessary routine
Ante-natal care is increasingly viewed by fathers 
and young people as a necessary routine, primarily 
aimed at women. Fathers did not have a problem 
with this; although they felt ante-natal care could 
make more of an effort to engage with them. 
Most men and women did not realise they could be 
invited to have a test for sickle cell or if they had 
been tested, what the disorder was. 
Some fathers also had no idea of the difference 
between sickle cell disorder and carrier status. 
Discussions with young people confirmed this, 
demonstrating a need for general awareness-
raising, which they said should ideally begin before 
ante-natal care is offered. 
Young people and fathers also spoke of the difficulty 
of making decisions, when they knew little about 
sickle cell and its consequences.
The words ‘disorder’ and ‘disease’ linked to 
sickle cell are understood negatively by fathers. 
Furthermore, some fathers who regarded 
themselves as asymptomatic did not see the need 
to be screened as they assumed they could not be a 
trait carrier. The perception of sickle cell as a ‘black’ 
or ‘ethnic’ disease persists among young people, 
fathers and practitioners too. This can sometimes 
cause confusion about why an invitation is given 
and to whom. It also means that screening can be 
perceived as stigmatising. 
“…because even though I got tested (…) I didn’t 
know, even though I was told to get the test done, I 
didn’t still know much about sickle cell.” 
FAther, 32, AFrICAn orIgIn
“If they don’t [know] about the disease (…) they’re 
not going to know about the trait.” 
young WoMAn, AFrICAn CArIbbeAn orIgIn
“In my circle of friends or family (…) it’s not 
something that we’re aware of, or it’s not 
something that’s talked about and it’s not the 
norm for you to just get tested and talk to other 
individuals and tell them.” 
young WoMAn, AFrICAn orIgIn
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Young people and fathers associated screening with 
having a responsibility for the health of the child 
and to prevent disabilities. A minority of participants 
felt testing should be mandatory.
Knowing one’s carrier status could also be useful in 
deciding who to have children with, which is why 
some fathers had been tested before entering ante-
natal care or would have liked to have been tested 
before pregnancy. Fathers also spoke about finding 
out that they were carriers after their children were 
born but not being offered access to counselling. 
Fathers of African origin or asylum seekers especially 
viewed screening as part of their citizenship duty. 
Young men, recent migrants and asylum seekers, 
however, were not always aware that they had a 
right to a GP, translation services or access to ante-
natal care. Moreover, even the most educated and 
articulate fathers said there were times when they 
were overwhelmed by the complexity of information 
they received. They, therefore, struggled to 
understand what was going on.
When services sensitively engaged with father’s 
concerns, screening was seen as empowering. 
This, however, was rare, and most men felt that 
services were concerned with greater biomedical 
surveillance, thereby creating a further potential for 
stigma. Men believed ante-natal services treated 
them as an instrumental genetic ‘risk’ rather than 
expectant fathers, who had an interest in their 
partners and child’s well-being. Some fathers also 
commented that they felt there was an element of 
blame and shame in being identified as a carrier, 
which they associated with their ability to pass 
the condition on to their offspring. Young men and 
women agreed and said they struggled to initiate 
conversations about their carrier status with family 
and peers.
Unmet expectations
Young men and women expected relationships of 
equality and involvement in services in tune with 
government policy. Fathers, however, felt this was 
rarely achieved in practice. Consequently, fathers 
felt marginalised during the process of ante-natal 
care. In keeping with a lack of engagement, some 
fathers shared experiences of stereotyping, racism, 
a lack of choice and in some cases, neglect. 
Fathers, young men and women felt they needed 
support, especially as they found ante-natal 
care confusing. They were not sure of what was 
expected of them or how they should make sense 
of the information provided. The research, however, 
identified several examples of good practice in 
which fathers felt supported and engaged. This was 
usually in the context of specialised professionals.
“I would recommend the test to other dads because 
it’s got, it’s just gotta be done and it’s for the 
wellbeing of the child.” 
FAther, 20, AFrICAn-CArIbbeAn orIgIn
“I think a lot of is pride (…) because if you are told that 
(…) you’ve got this disease that is a demoralising 
kind of thing. So, again it’s trying to inform people 
without hurting their pride or hurting their feelings 
(…), or making them feel so inadequate.” 
FAther, 35, AFrICAn CArIbbeAn orIgIn
“People struggle with the language, people struggle 
with the ‘white coat doctor’ or the very ‘white, 
grey-headed specialists’ that you’re dealing with 
(…) I find it sometimes very intense and challenging 
(…) I am not saying challenged but economically 
challenged, so they’re probably working nine to 
nine, doing twelve hours and stuff like, and all that 
processing all of this, you know, might also be a 
challenge.” 
FAther, 38, AFrICAn orIgIn
“That’s what it felt like but then I just, again, I made 
an assumption that,  okay, a lot of fathers, especially 
in certain areas and from ethnic minorities, they’re 
not really that supportive, so perhaps they had 
that perception. But I just thought it was unfair, 
‘cos I wasn’t one of them, you know? But I, in fact, 
throughout the pregnancy, I felt like that. There were 
times when it would be, it would be like mother and 
person, who’s the third guy in the room?” 
FAther, 27, AFrICAn orIgIn
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Nonetheless, some health care professionals, 
although indicating a commitment to a ‘couple-
centred’ approach, struggled to put this into 
practise because of operational barriers and 
resource constraints. Furthermore, while some 
mothers and fathers may no longer be together, 
fathers still wanted engagement even if the future 
relationship with the mother was uncertain. Fathers 
envisaged a relationship with their children and felt 
they had a ‘right’ to be included in decision-making. 
Practitioners found this difficult to negotiate.
Other fathers expressed the need for support 
in coming to terms with fatherhood, especially 
when the pregnancy might have been unexpected 
or there were difficulties. More generally, most 
fathers felt the social and emotional consequences 
of becoming a father were neglected by services 
because of the emphasis on testing. Additionally, 
they might be worried about other health issues, 
the mother’s health or other conditions affecting 
the baby; testing for sickle cell might not be high on 
the father’s agenda. 
Organisational barriers to engagement and 
informed choices
Practitioners and commissioners identified re-
organisation of the NHS, limited resources and 
a lack of understanding about future population 
needs as detrimental to facilitating choice. Lack 
of continuity was also seen to undermine timely 
interventions. Some practitioners, for example, 
noted that mothers often had contact with many 
different midwives when pregnant. Equally fathers 
felt a good relationship between mother, father 
and midwife was key to engagement and the 
exercise of choice. This is why fathers highly valued 
continuity of care. In addition, fathers related how 
much they appreciated the specialist sickle cell 
nurses, genetic counselling and consultants with 
specialist knowledge. Fathers spoke of how these 
practitioners were able to support them, their wives 
and children during the process of making difficult 
decisions.
All fathers related concerns about screening 
in primary care; from inability to get timely 
appointments; insensitive requests to also test 
for HIV in addition to sickle cell; and a lack of GP 
knowledge when offering choice and understanding 
the consequences of different carrier states.
Negotiating screening
The invitation to test the father of the baby 
for sickle cell has to be negotiated by service 
practitioners through the mother. The closeness 
of the couple relationship and influence of the 
(extended) family and how they view sickle 
cell could be important factors in how couples 
talk about ante-natal screening. Fathers felt 
practitioners did not always understand this. 
Some fathers had particular anxieties about the 
consequences of sickle cell, especially if they had 
previous experiences of the condition. Many fathers 
also alluded to a culture of silence, cultural myths 
and taboo linked to sickle cell. 
“But certainly a lot of the men do ask questions and 
we make sure that they know that they’re both in 
the process, not just the woman. It’s not a woman’s 
issue, it’s a couple’s issue, and therefore we give 
him as much chance to ask questions as we do 
her. I certainly always say to them, you know, ‘Do 
you have questions to ask me? Do you understand 
it?’ I ask him about his siblings, I ask him about his 
family, as well as I ask the woman. So, the focus is 
not always the woman, it’s about, the focus is on 
them as a couple, and I think, you know, certainly 
one is to get that balance, so that the guy doesn’t 
feel as if he’s just an addendum to his partner.” 
heAlth CAre ProFeSSIonAl
“You know, back home, over there, they have an 
idea about people who does have sickle cell, that 
they cannot live over eighteen years old (…) I’ve 
seen people around me dying and then I don’t 
know exactly what was the death relating to. By 
coming over here, that opened a bit of my mind, 
especially through my wife, and having a kid who 
is a sickle cell.” 
FAther, 42, AFrICAn orIgIn
“Yes, the sickle cell nurse at the time was very 
good. Very supportive. She came around to visit 
quite often, supporting my wife. My wife was 
so emotional, you know, and there was always 
that worry, oh, you know, before the child was 
born mostly, how is it going to, how are we 
going to live?” 
FAther, 42, AFrICAn orIgIn
5
“Men feel that, you know, they mustn’t be seen to 
be defective in any way and therefore, you know, 
when you test them and find that they’re a carrier, 
you know, they feel that it means that they are 
weaker, and the whole concept of being weak 
is paramount to saying that they’re not really a 
man and they’re not manly because they’ve got 
this defect. (…) the cultural attitudes to sickle cell 
disease, particularly in Nigeria, is very pronounced 
in that, you know, people feel they’ll be rejected 
if it is known that they’ve got a child with the 
disease or that they themselves carry, you know, 
this unusual haemoglobin.” 
heAlth CAre ProFeSSIonAl
Fathers also doubted some practitioners’ 
commitment to couple-centred care. Fathers 
felt the focus was nearly always on the women 
and although they understood this, many felt 
practitioners were reluctant to challenge mothers’ 
views. Fathers understood they had an important 
role in supporting their partner, but that service 
provision was poorly adapted to facilitate this.
Some mothers were said by fathers to control 
decision making and not consult with the father. 
They were also said to refuse male involvement; 
limit the information they give men; blame 
men for non-involvement; use men as a reason 
for not taking certain tests or let men take the 
responsibility for all decision making. Such 
comments, whatever their merit and validity, 
demonstrate the potential complexity of 
communication during ante-natal care, particularly 
since fathers often felt they had little opportunity 
to discuss mothers’ decisions with health care 
professions.
Overall, most mothers and fathers felt under 
pressure to ensure ‘ideal’ displays in ante-natal 
care in a way that demonstrated their competence 
as responsible parents or present a perfect front. 
This perhaps explains why some fathers felt 
judged, while a few felt they could not live up to 
what they thought was expected of them by both 
mothers and practitioners. Further, not all fathers 
were comfortable with the idea of fatherhood 
especially if there was a chance their unborn child 
had a disability. These fathers said they had little 
opportunity to discuss their anxieties, particularly 
since they were aware of the negative moral 
ascriptions associated with such views. 
The difficulties faced by service provision when 
offering good quality care and specialist support 
occurred irrespective of a father’s ethnic origin. 
Nonetheless, fathers noted that information 
about screening and ante-natal care was largely 
medicalised and not especially culturally sensitive. 
Some practitioners, however, did demonstrate 
sensitivity to fathers’ concerns. 
The role of voluntary and community organisations 
in providing balanced information and support 
to carriers cannot be overstated. Voluntary and 
community organisations were especially useful 
in providing information about children and adults 
living successfully with sickle cell disorders. 
Such organisations were also trusted by fathers, 
especially among those who have had negative 
experiences of NHS provision.
“(…) because she were really affected by the news. 
I was trying to just be there for her. Just to help 
her take the shock (…) No disagreement, they 
were things she wanted because she didn’t want 
to get rid of the baby, so I have to go for it.”  
FAther, 37, AFrICAn orIgIn
“(…) they won’t even go to their own GP, let alone 
for something like this. So, coming to our centre is 
a major thing. And if we’re not there I think, to be 
honest, I don’t believe that people will, they’re not 
going to all start running to their GP  because they 
haven’t done it in the past and they’re certainly 
not going to be going directly into the hospitals. We 
were filling that gap. I think our service was filling 
that gap, and it was even better if they could come 
to our centre or go to somewhere in the community 
where they felt comfortable, you know. That’s the 
first port of call. People have to feel comfortable 
and comfortable in a place that they know. That 
they can trust. That the people are experienced and 
can understand where they’re coming from.”
 VoluntAry SeCtor ProFeSSIonAl
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“Yeah, if you ask me today to choose again for that 
injection I’m going to say no, because I can’t see 
the difference. I mean later on, I was thinking that 
as soon as we, you know that the baby is sickle cell 
disease, you start the treatment.” 
FAther, 38, AFrICAn orIgIn
Divisive Ethical Issues 
Health care professionals are aware of how 
screening can be ethically divisive. Some warn of 
a subtle pressure being exerted on them to test 
fathers to enable them to meet targets. Others 
explained they could cajole fathers and talk about 
‘asking’ or ‘having the father tested’ rather than 
‘inviting fathers’. 
Both professionals and fathers related how 
information is not always shared among different 
practitioners or carried over to subsequent 
pregnancies. This undermined fathers’ confidence in 
service provision. Fathers also expressed concerns 
about privacy and confidentiality and wanted to 
know more about what would happen to their test 
results. 
Another area of concern for fathers was around 
prenatal diagnosis (PND). This is a test to find out if 
a baby has sickle cell. Fathers felt it was presented 
as an automatic response as soon as they were 
identified as an ‘at risk’ carrier couple. Fathers felt 
the risk of PND was sometimes downplayed and 
more generally, would have liked more support 
throughout the process. Fathers felt especially 
unsupported if results indicated that the unborn 
child had sickle cell and questioned the ethical 
provenance of phrases like ‘testing for the baby’s 
health’ when the baby could be tested after birth. 
This is why fathers commented on the need for 
more sensitivity on the part of practitioners and 
especially midwives. Several fathers related feeling 
as if they and their wives were being pressurised by 
midwives towards termination at very late stages in 
pregnancy. 
Most fathers agreed there was a need for more 
information, support and resources during ante-
natal care and testing for sickle cell. Some fathers 
also related examples, where even after having 
affected children, they were not informed or given 
access to reproductive technologies in subsequent 
pregnancies. Fathers also remarked on needing to 
understand the care their child will receive if they 
did have a sickle cell disorder. Overall, fathers felt 
that once identified as ‘at risk’, there was little 
detailed discussion of the choices of treatment, 
research and care of those born with sickle cell 
disorders. They felt this was important information 
to have, when making a decision about what to do 
next.
Fathers expressed doubts about how much choice 
they really had during ante-natal screening and few 
thought they had made informed decisions. They 
felt, for example, it was their responsibility to ask 
the correct questions and actively seek information 
from other sources. 
Additionally, those who felt they received poor care 
or experienced racism found it difficult to lodge a 
complaint.
“That’s their choice. But, you know, sometimes 
for us it’s difficult because then our managers ask 
what we should do if they don’t want to contact, 
and why you don’t test them? What are you doing 
with those fathers who refuse testing? So, we 
encourage them by giving them information, but 
we can’t force them. This is informed choice, is 
not forced choices. So, some fathers, they refuse 
straight away. “Yes, we know, and I don’t want a 
test.” And sometimes, as you say, they have other 
factors why they don’t want to.” 
heAlth CAre ProFeSSIonAl
“As I said, it’s only been a couple of times that I’ve 
had that happen, cos I think sometimes you can 
shame, this sounds really bad, you can shame them 
into having the test (…) .” 
heAlth CAre ProFeSSIonAl
“We’ve kind of come to terms with knowing that 
it’s not their responsibility, it’s, to feed us with 
the information that we need, it’s rather more our 
responsibility to ask to get that information out of 
them.” 
FAther, 40, ASIAn orIgIn
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Conclusion
Fathers expressed ambivalence about their 
encounter with ante-natal care. They were familiar 
with an emphasis on couple centred care, which 
they appreciated. Their experiences, however, often 
belied this emphasis. Consequently, many fathers 
felt marginalised by current provision, which might 
explain their lack of engagement with screening 
services. From a father’s point of view, ante-natal 
care seems to conceptualise them as a ‘risk’ rather 
than a father with rights to care, who can refuse 
testing and request counselling; irrespective of what 
choice he makes.
Fathers commented on how supported they felt 
when they encountered health care professionals 
that engaged with them, gave them space to talk 
and encouraged them to ask questions. Health care 
professionals who respected them as prospective 
fathers demonstrated examples of good practice, 
which promoted good care and built trust. Fathers 
spoke especially highly of their contact with 
professionals such as specialist nurses, genetic 
counsellors or voluntary sector professionals. 
Unfortunately, such contact was the exception 
rather than the rule. 
Health care services cannot engage with all 
the barriers our research identified, such as 
difficulties for working men to attend ante-natal 
appointments. However, services can become 
more inclusive by ensuring involvement. The policy 
commitment to ensuring men become an embodied 
part of ante-natal care, means there needs to be a 
genuine commitment to couple centred care. This 
is unlikely to be straightforward for both practical 
and philosophical reasons. However, it would be 
useful to have a considered debate on what the 
role of the father should be, in a way that does 
not compromise the care or rights of the mother. 
Further, young people, migrants and asylum 
seekers, indicated a lack of understanding about 
what services they had a right to access, where 
they could find those services and - more generally 
- the choices available to them. These fathers 
often said they experienced more problems such as 
racism, disempowerment, marginalisation or lack of 
choices. Our research also indicates a more general 
need for ethical training among practitioners, 
especially in relation to reflecting on their own 
values, when facilitating choice. 
Sickle cell is a transnational issue and part of 
a global public health agenda. Information on 
sickle cell, however, is largely given during 
ante-natal care, with a focus on medical and 
genetic consequences, rather than being socially 
embedded. Such information rarely reflects the 
complexities of people’s lives. Fathers expressed 
concerns about the lack of possibilities and 
capabilities on the part of health care agencies 
to support choice; and when investing in better 
support for carriers and people with sickle cell 
disorders across the life-course. Ethically, screening 
provision should exist alongside investments in 
care and a commitment to encouraging a vibrant 
voluntary sector. This will help facilitate genuine 
choice among couples. 
recommendations
Our recommendations are based on current good 
practice that engages and empowers men, while 
being sensitive to the needs of the mothers. Such 
good practice is already being offered by some 
practitioners. Fathers would like to see good 
practice more widespread.
Recommendations for Mothers, Fathers and 
Families
 § Sickle cell is the most common genetic disorder 
in the United Kingdom. Yet many health 
care professionals may not be aware of the 
condition. Ensure you get the access to the best 
services that you feel that you need.
 § Sickle cell can affect anybody but is more 
common in people of African, African-
Caribbean, Indian, Arab and Southern 
Mediterranean origin. In order to find out if you 
may be affected, try and gain an awareness of 
your family history and health. 
 § Young people need role models to understand 
how to talk about these issues that affect them. 
This includes their families, friends and health 
care professionals.
“I think all this attention on screening is because it’s 
cheap. It’s taking the easy way out. Screening just 
tells you more of the people that are ill, the people 
that have the disease, and you see why I don’t 
like it in a way is, even though it’s a choice, and 
that’s something I’ve said to my wife, (...) probably 
that’s reducing the, more people with sickle cell, so 
reduce the costs.”
FAther, 38, AFrICAn orIgIn
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 § Information on sickle cell disorders and carrier 
status may not always be given in school or 
may focus purely on the medical or genetic 
consequences. Young people also need to gain 
an understanding of what it means to live with 
sickle cell.
 § Testing for sickle cell can occur at any time and 
is your choice to make. You do not have to be in 
a relationship or thinking about children to have 
a test. 
 § If you are a carrier or have sickle cell, do 
become aware of your reproductive choices 
regardless of whom you fall in love with. It 
is important to be aware of all the options 
available to you. 
 § Generally, a woman will be invited to have a test 
for sickle cell during ante-natal care to find out 
if she is a carrier. If she is a carrier, her partner 
will be invited for a test during ante-natal care. 
These tests are not routine but offer choices 
with pros and cons.
 § If you have been tested elsewhere or outside 
of the United Kingdom, you may be invited to 
repeat that test despite knowing your carrier 
status. Discuss this choice and why it is being 
offered to you.
 § If you and your partner are both found to be 
carriers, there is a one in four chance that 
your child might be affected. You will be 
offered counselling. Discuss what questions 
you want to ask beforehand. Consider gaining 
follow-up information with a voluntary sector 
organisation.
 § You can have a test during pregnancy to find 
out if your child has a sickle cell disorder. There 
is a small risk associated with miscarriage. No 
one can tell you how severely affected a child 
will be. Treatments are, however, available. 
Your choice is to continue with the pregnancy 
or terminate it. This is not an easy decision to 
make and a decision that is right for one person 
might not be right for you. People, for example, 
agree to a test for different reasons; some use it 
to make a decision about termination, others to 
prepare themselves for the birth of a child who 
has the condition. It is your and your partner’s 
choice about what to do. 
 § Your child will also be tested after it is born. If it 
has a sickle cell disorder, the child will be given 
appropriate treatment. Discuss when and why 
you need to find out and if prenatal testing is an 
option for you.
 § If you have a child with sickle cell, it is 
sometimes useful to get in touch with voluntary 
sector organisations, medical specialists and 
local services to ensure that you have all 
support you need.
 § Sickle cell is a variable condition and affects 
everyone differently but can be very serious. 
There is at present no cure. Bone marrow 
transplants are sometimes used, but are not 
accessible for everyone. Transplants also carry 
serious health risks. 
 § Mothers, fathers and siblings need support but 
are often overlooked in services. This is a long 
standing problem. It is, therefore, important for 
families to understand what is available to them 
and support each other. Discuss if you want to 
be tested too and what that means for you as a 
family. 
Recommendations for Health Care 
Professionals: Testing Men
“…if you always grew up, grew up knowing what 
you were and everything, I don’t think it would be a 
problem bringing it up.” 
young MAn, MIxeD ethnIC orIgIn
“I personally really think that this should be 
discussed when they are at secondary school from 
the age of thirteen. When they start to be taught 
about sex education, I think that’s when they need 
to be taught about the issue around screening and 
obviously sickle cell and thalassaemia.” 
heAlth CAre ProFeSSIonAl
“Just to be asked that would make me feel invited to, 
you know, be able to put my point across (…) you’re 
not just feeling (…) it doesn’t just feel like a process 
that you’re going in this end and you’re going to 
come out at the other end, that you’re actually 
aware of what’s happening every step of the way, 
and I think little things like that would make a 
massive difference.” 
FAther, 40, ASIAn orIgIn
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 § Men related numerous barriers to access 
services. Make fathers feel welcome, valued and 
respected. 
 § Ensure services are accessible to working 
fathers and young fathers.
 § The test is a polite invitation. Fathers, however, 
sometimes felt under pressure to have this test. 
Facilitate choice and discuss the options with 
families. Fathers appreciate this. 
 § Has dad received the Tests for Dads leaflet or an 
NHS letter inviting him to get tested? Does he 
have any questions? Does he know what sickle 
cell is?
 § Fathers find ante-natal care confusing. Have 
you explained why you are doing the test? And 
discussed the pros and cons of testing?
 § Have you explained that this test is just for 
sickle cell and nothing else?
 § If a dad wants a HIV test or STI test refer him to 
GP or STI clinic.
 § Show men exactly what you are going to do 
with their blood, explain how it will be kept and 
illustrate the labelling. Fathers said they were 
reassured by such explanations. Explain how 
long results will take. 
 § Draw attention to what happens if results show 
he is carrier. Ensure that he can always have 
someone to contact if he has questions. 
 § Father can sometimes be anxious about 
fatherhood. This is their priority rather than 
agreeing to have a test. Reassure them. 
 § Fathers understand why ante-natal care 
focuses on the mother. They would, however, 
like to see more couple centred approaches, in 
which they can express their needs. 
 § Understand that some men may refuse testing. 
This is their choice. They may test at another 
time or never at all. Ensure that fathers are 
aware they can make choices. 
 § You can probe to find out why a man refuses 
testing. Be non-judgemental and ask if he has 
concerns about needles or what a blood test 
may reveal. 
 § Ask if he has been tested before and where. 
Extra sensitivity is needed if a father is identified 
as being from a country that has a high 
incidence of faulty tests or where counselling is 
required before marriage.
 § Ensure fathers have access to balanced 
information on the life of someone with a sickle 
cell disorder. For example, explain that new 
born screening enables early treatment and 
precautions to be put in place to best care for 
their child. In this respect, the voluntary sector 
can be an important source of information 
about the lives of families with a child with 
sickle cell.
Recommendations for GPs
 § Ensure that sickle cell is brought up in general 
consultations if a genetic possibility and probe 
family histories if needed. Fathers and mothers 
sometimes feel it is too late to offer testing 
when pregnant. They would like to be offered a 
test sooner.
 § Irrespective of apparent ethnicity consider 
offering a screening test for sickle cell/
thalassaemia as part of the package offered 
when first registering at a GP surgery.
 § Respond positively to requests from any 
patients for a sickle cell screening test. Explain 
difference between sickle cell disorder and 
‘carrier’ status.
 § Testing should be an individual’s choice but 
discuss pros and cons. Ensure you have leaflets 
and information available. At present, fathers do 
not feel they are making informed choices. 
 § If tests have taken place elsewhere, probe and 
suggest repeat tests if necessary.
 § Be ready to explain carrier status, where to go 
for counselling and implications for pregnancy. 
Understand how some couples might find 
screening stigmatising.
“They feel that something else is gonna come up. 
So, if they smoke. Give you an example, if they do 
drugs, smoke weed or they do cocaine or whatever 
they do in their private life, they just think that the 
screening is gonna highlight all that, okay?” 
heAlth CAre ProFeSSIonAl
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 § Provide information about reproductive 
possibilities if mother and father are both 
carriers or one partner has sickle cell. 
 § Ensure you are up to date with what your local 
voluntary sector organisation offers and know 
where to refer your patients.
Recommendations for Genetic Counsellors
 § Having time with a specialist is highly valued by 
all parents but they feel that they cannot always 
articulate their questions. Make sure that they 
feel supported to ask ‘stupid questions’ and 
ensure access to interpreters if required. Make 
sure mothers and fathers get to ask all their 
questions. 
 § Ensure equity in services and access to all 
reproductive choices for everyone. This means 
giving choices to couples with carrier status and 
both men and women who have sickle cell. 
 § When dealing with young men explain how to 
instigate conversations with peers about sickle 
cell testing. Highlight role models and positive 
links to sickle cell to combat possible stigma.
 § Be sensitive to the lack of awareness and 
information about sickle cell in British society. 
It is still perceived as a ‘black disease’, so show 
understanding to how this may affect men’s 
conceptions of identity and understanding of 
testing.
 § Be sensitive to the differing socio-cultural 
background of mothers and fathers and role of 
extended family. 
 § Timing is crucial for parents. Test results have 
to be given early to enable men and women to 
make informed choices that they find difficult.
 § Check information given about carrier status 
and why a card is given. Explain specific 
situations a person may encounter such as; 
operations, high altitudes and why donating 
blood is possible. 
 § Make sure that you explain that prenatal 
diagnostic testing is neither a cure nor a 
treatment for sickle cell and has a risk of 
miscarriage. Explain why you are giving this 
choice but also that the child can be tested after 
birth. 
 § Some fathers may only find out they might be 
carriers after a child is born. Ensure access to 
counselling services for these fathers.
 § Ensure reproductive choices are given for the 
next pregnancy.
Recommendations for Clinical 
Commissioning Groups and Specialist 
Commissioning
 § Be aware that sickle cell is a leading genetic 
condition in England. Obtain up-to date 
figures from NHS England. For example at the 
time of writing 1 in 450 ‘White-British’ new-
borns carries a sickle cell-relevant gene, 1 
in 1850 of all births in the UK is a child with 
sickle cell disorder and 1 in 70 is a sickle cell or 
thalassaemia carrier.
 § Health care professionals, such as midwives 
and genetic counsellors, feel their resources 
and time are being stretched and that the focus 
is more on delivering targets than ensuring 
proper and appropriate care. They would like 
more support to ensure good care for mothers 
and recognition of the difficulties they face 
in providing this. If fathers are encouraged 
to engage with ante-natal care, especially if 
genetic testing of men becomes part of ante-
natal or primary care, planning for the future 
needs of this group is essential. Practitioners 
would also like more advice and support on how 
best to engage with fathers.
 § Consider making resources available to support 
GPs who offer sickle cell screening in primary 
care, or consider commissioning voluntary 
groups to undertake this provision.
 § More education and awareness about sickle 
cell is needed. This does not necessarily mean 
providing clinical information or ensuring 
that genetic education is provided in schools. 
Parents require information linking the 
social consequences of decision making with 
clinical material. Information also needs to be 
more readily accessible (such as translated 
accounts, using social media and ‘apps’ and 
more community resources) and in some cases 
specifically geared towards men.
 § Involve the local voluntary and community 
services to ensure that outreach includes 
fathers. Voluntary sector providers have an 
excellent track record of engaging with local 
communities and are often more trusted than 
NHS provision. 
 § Ensure that patients, carriers and voluntary 
organisations for sickle cell are involved in 
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Clinical Commissioning Groups as well as 
Specialist Commissioning. Consider setting 
up a taskforce to ensure this and make sure 
community members with a good knowledge of 
sickle cell are included.
 § Ensure that services are inclusive of fathers and 
that they are welcomed across the board (from 
ante-natal care to more specialist provision). 
This would also achieve equity and reduce 
inequalities.
 § Ensure the provision of specialist services, as 
well as counselling, for fathers and families 
affected by carrier status. 
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useful Contacts
Most major cities now have a Centre for Sickle Cell and Thalassaemia. To find yours: www.sickle-thal.nwlh.nhs.uk/Information/
NationalSickleCellThalassaemiaCentres.aspx
The voluntary sector contacts of the organisations that participated in this report:













Tel: 0121 525 0556
Email: oscar-sandwell@hotmail.co.uk
Web: www.oscarsandwell.org.uk
Sheffield Sickle Cell and Thalassaemia 




















Tel: 0121 212 9209
Email: admin@oscarbirmingham.org.uk
Web: www.oscarbirmingham.org.uk 
Liverpool Sickle Cell and Thalassaemia 
Support Group





Leeds Sickle Cell Support Group
Based at: The Reginald Centre
263 Chapeltown Road
Leeds LS7 3EX
Tel: 0113 843 4348
Email: sue.jammeh@nhs.net
 










NHS Sickle Cell and Thalassaemia Screening Programme (now part of Public Health England) contains information and leaflets about 
screening, sickle cell and carrier (trait) statuses. This is also in different languages: http://sct.screening.nhs.uk/
You can watch videos of people discussing their experiences of sickle cell, couples’ decisions during screening and what carrier (trait) 
status means: http://sct.screening.nhs.uk/stories
They also have a link to Healthtalkonline which is a website about people’s experiences and is in languages such as French, Urdu and 
Portuguese: http://healthtalkonline.org/peoples-experiences/pregnancy-children/screening-sickle-cell-and-beta-thalassaemia/
topics
NHS Newborn Blood Screening Programme (now part of Public Health England) explains the blood spot test used in babies to identify 
sickle cell and carrier (trait) status: http://newbornbloodspot.screening.nhs.uk/
NHS CHOICES has information and videos of people and children talking about what it’s like to live with sickle cell: www.nhs.uk/video/
pages/sickle-cell-anaemia.aspx
Planet Sickle Cell is a special website for children living with sickle cell: www.sicklecellsociety.org/websites/123reg/LinuxPackage22/
si/ck/le/sicklecellsociety.org/public_html/pages/children
